DK2768972T3 - Fremgangsmåder og sammensætninger til nukleinsyresekventering - Google Patents
Fremgangsmåder og sammensætninger til nukleinsyresekventering Download PDFInfo
- Publication number
- DK2768972T3 DK2768972T3 DK12766838.2T DK12766838T DK2768972T3 DK 2768972 T3 DK2768972 T3 DK 2768972T3 DK 12766838 T DK12766838 T DK 12766838T DK 2768972 T3 DK2768972 T3 DK 2768972T3
- Authority
- DK
- Denmark
- Prior art keywords
- nucleotide
- sequencing
- incorporation
- fluorescence
- fluorophore
- Prior art date
Links
- 238000012163 sequencing technique Methods 0.000 title claims description 226
- 238000000034 method Methods 0.000 title claims description 125
- 239000000203 mixture Substances 0.000 title claims description 72
- 150000007523 nucleic acids Chemical class 0.000 title description 83
- 102000039446 nucleic acids Human genes 0.000 title description 74
- 108020004707 nucleic acids Proteins 0.000 title description 74
- 125000003729 nucleotide group Chemical group 0.000 claims description 336
- 239000002773 nucleotide Substances 0.000 claims description 302
- 238000006243 chemical reaction Methods 0.000 claims description 124
- 238000010348 incorporation Methods 0.000 claims description 117
- 238000003384 imaging method Methods 0.000 claims description 98
- 238000001514 detection method Methods 0.000 claims description 94
- 238000003776 cleavage reaction Methods 0.000 claims description 85
- 230000007017 scission Effects 0.000 claims description 78
- 238000003786 synthesis reaction Methods 0.000 claims description 36
- 230000015572 biosynthetic process Effects 0.000 claims description 29
- 102000040430 polynucleotide Human genes 0.000 claims description 29
- 108091033319 polynucleotide Proteins 0.000 claims description 29
- 239000002157 polynucleotide Substances 0.000 claims description 29
- 150000001540 azides Chemical class 0.000 claims description 19
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims description 13
- 150000002148 esters Chemical class 0.000 claims description 11
- 238000001917 fluorescence detection Methods 0.000 claims description 9
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 claims description 7
- 150000002009 diols Chemical class 0.000 claims description 7
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims description 7
- 150000003457 sulfones Chemical class 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 1
- 239000000975 dye Substances 0.000 description 132
- 239000000523 sample Substances 0.000 description 88
- 239000003153 chemical reaction reagent Substances 0.000 description 52
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 44
- 230000005284 excitation Effects 0.000 description 42
- 229960002685 biotin Drugs 0.000 description 39
- 239000011616 biotin Substances 0.000 description 39
- 108020004414 DNA Proteins 0.000 description 37
- 239000007850 fluorescent dye Substances 0.000 description 36
- 238000005516 engineering process Methods 0.000 description 32
- 238000000295 emission spectrum Methods 0.000 description 28
- 235000020958 biotin Nutrition 0.000 description 23
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 22
- 239000002202 Polyethylene glycol Substances 0.000 description 21
- 229920001223 polyethylene glycol Polymers 0.000 description 21
- 108010090804 Streptavidin Proteins 0.000 description 19
- 125000003545 alkoxy group Chemical group 0.000 description 18
- 230000008859 change Effects 0.000 description 18
- 238000000695 excitation spectrum Methods 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- 238000009396 hybridization Methods 0.000 description 16
- 229920000642 polymer Polymers 0.000 description 14
- HWCKGOZZJDHMNC-UHFFFAOYSA-M tetraethylammonium bromide Chemical compound [Br-].CC[N+](CC)(CC)CC HWCKGOZZJDHMNC-UHFFFAOYSA-M 0.000 description 14
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 12
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 11
- 239000000758 substrate Substances 0.000 description 11
- 230000007704 transition Effects 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 10
- 238000002189 fluorescence spectrum Methods 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 230000003321 amplification Effects 0.000 description 9
- 239000011324 bead Substances 0.000 description 9
- 239000000839 emulsion Substances 0.000 description 9
- 239000011807 nanoball Substances 0.000 description 9
- 238000003199 nucleic acid amplification method Methods 0.000 description 9
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 230000004048 modification Effects 0.000 description 8
- 238000012986 modification Methods 0.000 description 8
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 7
- 230000000295 complement effect Effects 0.000 description 7
- 230000004069 differentiation Effects 0.000 description 7
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 7
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 7
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 7
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 7
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 7
- 239000001226 triphosphate Substances 0.000 description 7
- 235000011178 triphosphate Nutrition 0.000 description 7
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 7
- 102000053602 DNA Human genes 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 150000003003 phosphines Chemical class 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000001308 synthesis method Methods 0.000 description 6
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- JMXMXKRNIYCNRV-UHFFFAOYSA-N bis(hydroxymethyl)phosphanylmethanol Chemical compound OCP(CO)CO JMXMXKRNIYCNRV-UHFFFAOYSA-N 0.000 description 5
- 239000003638 chemical reducing agent Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- -1 nucleotide triphosphates Chemical class 0.000 description 5
- 238000010791 quenching Methods 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- PZBFGYYEXUXCOF-UHFFFAOYSA-N TCEP Chemical compound OC(=O)CCP(CCC(O)=O)CCC(O)=O PZBFGYYEXUXCOF-UHFFFAOYSA-N 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 230000021615 conjugation Effects 0.000 description 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 4
- 229920002477 rna polymer Polymers 0.000 description 4
- 238000007841 sequencing by ligation Methods 0.000 description 4
- 239000011550 stock solution Substances 0.000 description 4
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 3
- 229930024421 Adenine Natural products 0.000 description 3
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 102000003960 Ligases Human genes 0.000 description 3
- 108090000364 Ligases Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920005654 Sephadex Polymers 0.000 description 3
- 239000012507 Sephadex™ Substances 0.000 description 3
- 229960000643 adenine Drugs 0.000 description 3
- 239000012491 analyte Substances 0.000 description 3
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 3
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 3
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 3
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 3
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 3
- 239000005546 dideoxynucleotide Substances 0.000 description 3
- 125000002228 disulfide group Chemical group 0.000 description 3
- VHJLVAABSRFDPM-ZXZARUISSA-N dithioerythritol Chemical compound SC[C@H](O)[C@H](O)CS VHJLVAABSRFDPM-ZXZARUISSA-N 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 238000010223 real-time analysis Methods 0.000 description 3
- 238000004007 reversed phase HPLC Methods 0.000 description 3
- 150000003384 small molecules Chemical group 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 3
- 239000003039 volatile agent Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- LLTDOAPVRPZLCM-UHFFFAOYSA-O 4-(7,8,8,16,16,17-hexamethyl-4,20-disulfo-2-oxa-18-aza-6-azoniapentacyclo[11.7.0.03,11.05,9.015,19]icosa-1(20),3,5,9,11,13,15(19)-heptaen-12-yl)benzoic acid Chemical compound CC1(C)C(C)NC(C(=C2OC3=C(C=4C(C(C(C)[NH+]=4)(C)C)=CC3=3)S(O)(=O)=O)S(O)(=O)=O)=C1C=C2C=3C1=CC=C(C(O)=O)C=C1 LLTDOAPVRPZLCM-UHFFFAOYSA-O 0.000 description 2
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 description 2
- 238000001712 DNA sequencing Methods 0.000 description 2
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 2
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 2
- 108091093037 Peptide nucleic acid Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 108020004682 Single-Stranded DNA Proteins 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 2
- 239000012148 binding buffer Substances 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 150000001615 biotins Chemical class 0.000 description 2
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 229940104302 cytosine Drugs 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 230000003292 diminished effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000013401 experimental design Methods 0.000 description 2
- 238000012632 fluorescent imaging Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 239000001046 green dye Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- SXQCTESRRZBPHJ-UHFFFAOYSA-M lissamine rhodamine Chemical compound [Na+].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O SXQCTESRRZBPHJ-UHFFFAOYSA-M 0.000 description 2
- 239000002853 nucleic acid probe Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000001044 red dye Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- 229940113082 thymine Drugs 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- VQTBINYMFPKLQD-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-(3-hydroxy-6-oxoxanthen-9-yl)benzoate Chemical compound C=12C=CC(=O)C=C2OC2=CC(O)=CC=C2C=1C1=CC=CC=C1C(=O)ON1C(=O)CCC1=O VQTBINYMFPKLQD-UHFFFAOYSA-N 0.000 description 1
- ILKQVTIMOGNSAS-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-(7-amino-4-methyl-2-oxochromen-3-yl)acetate Chemical compound O=C1OC=2C=C(N)C=CC=2C(C)=C1CC(=O)ON1C(=O)CCC1=O ILKQVTIMOGNSAS-UHFFFAOYSA-N 0.000 description 1
- DQUHYEDEGRNAFO-QMMMGPOBSA-N (2s)-6-amino-2-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CCCCN DQUHYEDEGRNAFO-QMMMGPOBSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- ISNKSXRJJVWFIL-UHFFFAOYSA-N (sulfonylamino)amine Chemical compound NN=S(=O)=O ISNKSXRJJVWFIL-UHFFFAOYSA-N 0.000 description 1
- DTMMZESZHTZRSO-UHFFFAOYSA-N 1-[(3-acetyloxy-4-methyl-2-oxochromen-7-yl)amino]-2,5-dioxopyrrolidine-3-sulfonic acid Chemical compound C1=C2OC(=O)C(OC(=O)C)=C(C)C2=CC=C1NN1C(=O)CC(S(O)(=O)=O)C1=O DTMMZESZHTZRSO-UHFFFAOYSA-N 0.000 description 1
- ZQXIMYREBUZLPM-UHFFFAOYSA-N 1-aminoethanethiol Chemical compound CC(N)S ZQXIMYREBUZLPM-UHFFFAOYSA-N 0.000 description 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-O 1H-indol-1-ium Chemical compound C1=CC=C2[NH2+]C=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-O 0.000 description 1
- HIYWOHBEPVGIQN-UHFFFAOYSA-N 1h-benzo[g]indole Chemical compound C1=CC=CC2=C(NC=C3)C3=CC=C21 HIYWOHBEPVGIQN-UHFFFAOYSA-N 0.000 description 1
- VGIRNWJSIRVFRT-UHFFFAOYSA-N 2',7'-difluorofluorescein Chemical compound OC(=O)C1=CC=CC=C1C1=C2C=C(F)C(=O)C=C2OC2=CC(O)=C(F)C=C21 VGIRNWJSIRVFRT-UHFFFAOYSA-N 0.000 description 1
- NNMALANKTSRILL-LXENMSTPSA-N 3-[(2z,5e)-2-[[3-(2-carboxyethyl)-5-[(z)-[(3e,4r)-3-ethylidene-4-methyl-5-oxopyrrolidin-2-ylidene]methyl]-4-methyl-1h-pyrrol-2-yl]methylidene]-5-[(4-ethyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoic acid Chemical compound O=C1C(CC)=C(C)C(\C=C\2C(=C(CCC(O)=O)C(=C/C3=C(C(C)=C(\C=C/4\C(\[C@@H](C)C(=O)N\4)=C\C)N3)CCC(O)=O)/N/2)C)=N1 NNMALANKTSRILL-LXENMSTPSA-N 0.000 description 1
- QCPFFGGFHNZBEP-UHFFFAOYSA-N 4,5,6,7-tetrachloro-3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 QCPFFGGFHNZBEP-UHFFFAOYSA-N 0.000 description 1
- VEJHUGGPLQWGPR-UHFFFAOYSA-N 4,7-bis(3-chloro-2-sulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid Chemical compound C=12C=CC3=C(C=4C(=C(Cl)C=CC=4)S(O)(=O)=O)C=C(C(O)=O)N=C3C2=NC(C(=O)O)=CC=1C1=CC=CC(Cl)=C1S(O)(=O)=O VEJHUGGPLQWGPR-UHFFFAOYSA-N 0.000 description 1
- YERWMQJEYUIJBO-UHFFFAOYSA-N 5-chlorosulfonyl-2-[3-(diethylamino)-6-diethylazaniumylidenexanthen-9-yl]benzenesulfonate Chemical compound C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S(Cl)(=O)=O)C=C1S([O-])(=O)=O YERWMQJEYUIJBO-UHFFFAOYSA-N 0.000 description 1
- VEQCRWBNBHJDSA-UHFFFAOYSA-N 6-amino-2-[2-[(2-iodoacetyl)amino]ethyl]-1,3-dioxobenzo[de]isoquinoline-5,8-disulfonic acid Chemical compound O=C1N(CCNC(=O)CI)C(=O)C2=CC(S(O)(=O)=O)=CC3=C2C1=CC(S(O)(=O)=O)=C3N VEQCRWBNBHJDSA-UHFFFAOYSA-N 0.000 description 1
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- YIXZUOWWYKISPQ-UHFFFAOYSA-N ATTO 565 para-isomer Chemical compound [O-]Cl(=O)(=O)=O.C=12C=C3CCC[N+](CC)=C3C=C2OC=2C=C3N(CC)CCCC3=CC=2C=1C1=CC(C(O)=O)=CC=C1C(O)=O YIXZUOWWYKISPQ-UHFFFAOYSA-N 0.000 description 1
- IGAZHQIYONOHQN-UHFFFAOYSA-N Alexa Fluor 555 Chemical compound C=12C=CC(=N)C(S(O)(=O)=O)=C2OC2=C(S(O)(=O)=O)C(N)=CC=C2C=1C1=CC=C(C(O)=O)C=C1C(O)=O IGAZHQIYONOHQN-UHFFFAOYSA-N 0.000 description 1
- 239000012099 Alexa Fluor family Substances 0.000 description 1
- 108010039224 Amidophosphoribosyltransferase Proteins 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-O Imidazolium Chemical compound C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- QPFYXYFORQJZEC-FOCLMDBBSA-N Phenazopyridine Chemical compound NC1=NC(N)=CC=C1\N=N\C1=CC=CC=C1 QPFYXYFORQJZEC-FOCLMDBBSA-N 0.000 description 1
- 108010004729 Phycoerythrin Proteins 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 229910052771 Terbium Inorganic materials 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
- HOUJZQLNVOLPOY-FCDQGJHFSA-N [(e)-(3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-ylidene)amino]thiourea Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11O/C(=N/NC(=S)N)C2=CC=CC=C21 HOUJZQLNVOLPOY-FCDQGJHFSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- MHHMNDJIDRZZNT-UHFFFAOYSA-N atto 680 Chemical compound OC(=O)CCCN1C(C)(C)C=C(CS([O-])(=O)=O)C2=C1C=C1OC3=CC4=[N+](CC)CCCC4=CC3=NC1=C2 MHHMNDJIDRZZNT-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- VYXSBFYARXAAKO-WTKGSRSZSA-N chembl402140 Chemical compound Cl.C1=2C=C(C)C(NCC)=CC=2OC2=C\C(=N/CC)C(C)=CC2=C1C1=CC=CC=C1C(=O)OCC VYXSBFYARXAAKO-WTKGSRSZSA-N 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 239000011162 core material Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- WQABCVAJNWAXTE-UHFFFAOYSA-N dimercaprol Chemical compound OCC(S)CS WQABCVAJNWAXTE-UHFFFAOYSA-N 0.000 description 1
- 239000001177 diphosphate Chemical group 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical group [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000001312 dry etching Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 1
- 238000013090 high-throughput technology Methods 0.000 description 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-O hydron;quinoline Chemical compound [NH+]1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-O 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- RPKCZJYDUKVMGF-UHFFFAOYSA-L lucifer yellow carbohydrazide dye Chemical compound [Li+].[Li+].[O-]S(=O)(=O)C1=CC(C(N(NC(=O)NN)C2=O)=O)=C3C2=CC(S([O-])(=O)=O)=CC3=C1N RPKCZJYDUKVMGF-UHFFFAOYSA-L 0.000 description 1
- DLBFLQKQABVKGT-UHFFFAOYSA-L lucifer yellow dye Chemical compound [Li+].[Li+].[O-]S(=O)(=O)C1=CC(C(N(C(=O)NN)C2=O)=O)=C3C2=CC(S([O-])(=O)=O)=CC3=C1N DLBFLQKQABVKGT-UHFFFAOYSA-L 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 235000019689 luncheon sausage Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 150000004712 monophosphates Chemical group 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- GWVCIJWBGGVDJJ-UHFFFAOYSA-N n-(4-aminophenyl)sulfonyl-n-(3-methoxypyrazin-2-yl)acetamide Chemical compound COC1=NC=CN=C1N(C(C)=O)S(=O)(=O)C1=CC=C(N)C=C1 GWVCIJWBGGVDJJ-UHFFFAOYSA-N 0.000 description 1
- WIXAQXKQLNRFDF-UHFFFAOYSA-N n-[4-[7-(diethylamino)-4-methyl-2-oxochromen-3-yl]phenyl]-2-iodoacetamide Chemical compound O=C1OC2=CC(N(CC)CC)=CC=C2C(C)=C1C1=CC=C(NC(=O)CI)C=C1 WIXAQXKQLNRFDF-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 230000005257 nucleotidylation Effects 0.000 description 1
- 239000000382 optic material Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 229920002120 photoresistant polymer Polymers 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940070891 pyridium Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006894 reductive elimination reaction Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229940043267 rhodamine b Drugs 0.000 description 1
- 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000005464 sample preparation method Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000011451 sequencing strategy Methods 0.000 description 1
- 238000002444 silanisation Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
- JGVWCANSWKRBCS-UHFFFAOYSA-N tetramethylrhodamine thiocyanate Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(SC#N)C=C1C(O)=O JGVWCANSWKRBCS-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229940071127 thioglycolate Drugs 0.000 description 1
- CWERGRDVMFNCDR-UHFFFAOYSA-M thioglycolate(1-) Chemical compound [O-]C(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-M 0.000 description 1
- 230000034005 thiol-disulfide exchange Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- PSVXZQVXSXSQRO-UHFFFAOYSA-N undecaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO PSVXZQVXSXSQRO-UHFFFAOYSA-N 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
- C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Chemical Kinetics & Catalysis (AREA)
Claims (14)
1. Fluorescensbaseret fremgangsmåde til sekventering ved syntese (SBS) til bestemmelse af sekvensen af et polynukleotid, som omfatter påvisning i en sekventeringsreaktion af inkorporeringen af tre forskellige typer påviselige nukleotidkonjugater i et polynukleotid og bestemmelse af inkorporeringen af en fjerde type nukleotid baseret på påvisningsmønstret af de tre forskellige typer påviselige nukleotider i polynukleotidet til derved bestemmelse af sekvensen af et polynukleotid, hvor inkorporeringen af tre forskellige typer påviselige nukleotidkonjugater påvises fra en signaltilstand; og hvor et første nukleotidkonjugat, der er bundet til en første fluorofor, påvises i en første kanal; et andet nukleotidkonjugat, der er bundet til en anden fluorofor, påvises i en anden kanal; et tredje nukleotidkonjugat påvises i den første kanal og den anden kanal, hvor det tredje nukleotidkonjugat er en blanding af konjugater, der adskiller sig ved at være bundet til en tredje fluorofor, der påvises i den første kanal, eller en fjerde fluorofor, der påvises i den anden kanal; og hvor inkorporeringen af den fjerde type nukleotid bestemmes fra en mørk tilstand.
2. Fremgangsmåde ifølge krav 1, hvor de fire fluoroforer er forskellige fluorescerende dele.
3. Fremgangsmåde ifølge krav 1, hvor den første fluorofor er identisk med den tredje fluorofor, og den anden fluorofor er identisk med den fjerde fluorofor.
4. Fremgangsmåde ifølge krav 2 eller 3, hvor inkorporeringen af det Ijerde nukleotid bestemmes ved fluorescenspåvisningsmønstret af de fluorescerende dele, og hvor fluorescenspåvisningsmønstret bestemmes ved en første og en anden billeddannelseshændelse.
5. Fremgangsmåde ifølge krav 4, hvor den første billeddannelseshændelse påviser et fluorescensmønster, der er forskelligt fra fluorescensmønstret, der påvises ved den anden billeddannelseshændelse.
6. Fremgangsmåde ifølge krav 5, hvor inkorporeringen af et eller flere nukleotider bestemmes ved forskellen i fluorescensmønstret mellem den første og anden billeddannelseshændelse.
7. Fremgangsmåde ifølge krav 1, hvor den ene eller de flere typer nukleotidkonjugater yderligere omfatter en eller flere linkersekvenser, og hvor den ene eller de flere linkersekvenser omfatter en eller flere af en spaltbar linker og en spacerlinker, hvor den spaltbare linker omfatter en eller flere spaltbare koblingsgrupper valgt fra gruppen, der består af et disulfid, en diol, en diazo, en ester, en sulfon, et azid, en allyl og en silylether.
8. Fremgangsmåde ifølge krav 1, hvor nukleotiderne omfatter fire modificerede nukleotidtyper, hvor tre modificerede nukleotidtyper er konjugeret til en eller flere påvisningsdele og en eller flere linkere placeret mellem nukleotidet og den ene eller de flere påvisningsdele, og hvor en fjerde nukleotidtype mangler en påvisningsdel, hvor påvisningen omfatter a) påvisning af et inkorporeringsmønster af de modificerede nukleotider i en sekventeringsreaktion til derved indfangning af et første påviseligt mønster, b) tilsætning af en eller flere sammensætninger til sekventeringsreaktionen til derved ændring af det første påviselige mønster og c) påvisning af et andet påviseligt mønster, og hvor d) sekvensen af polynukleotidprøven bestemmes baseret på de påviselige mønstre.
9. Fremgangsmåde ifølge krav 8, hvor inkorporering af den fjerde nukleotidtype bestemmes ved hjælp af fluorescenspåvisningsmønstrene af de andre tre nukleotidtyper i både det første og andet påviselige mønster.
10. Fremgangsmåde ifølge krav 8, hvor den ene eller de flere linkere omfatter en eller flere af en spaltbar linker og en spacerlinker.
11. Fremgangsmåde ifølge krav 8, hvor den ene eller de flere sammensætninger, der tilsættes til en sekventeringsreaktion til derved ændring af det første påviselige mønster, omfatter tilsætning afen eller flere af en spaltningsforbindelse og et bindingspartner-påvisningsdel-konjugat.
12. Sammensætning til anvendelse i fremgangsmåden ifølge krav 1, som omfatter: a) et første nukleotidkonjugat, der er bundet til en første fluorofor og påviseligt i en første kanal; b) et andet nukleotidkonjugat, der er bundet til en anden fluorofor og påviseligt i en anden kanal; c) et tredje nukleotidkonjugat, der er påviseligt i den første kanal og den anden kanal, hvor det tredje nukleotidkonjugat er en blanding af konjugater, der adskiller sig ved at være bundet til en tredje fluorofor, der er påviselig i den første kanal, eller en fjerde fluorofor, der er påviselig i den anden kanal; og d) et fjerde nukleotidkonjugat, der mangler en fluorescerende del.
13. Sammensætning ifølge krav 12, hvor de fire fluoroforer er forskellige fluorescerende dele.
14. Sammensætning ifølge krav 12, hvor den første fluorofor er identisk med den tredje fluorofor, og den anden fluorofor er identisk med den fjerde fluorofor.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161538294P | 2011-09-23 | 2011-09-23 | |
| US201261619878P | 2012-04-03 | 2012-04-03 | |
| PCT/US2012/056556 WO2013044018A1 (en) | 2011-09-23 | 2012-09-21 | Methods and compositions for nucleic acid sequencing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2768972T3 true DK2768972T3 (da) | 2017-09-25 |
Family
ID=46964103
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17180583T DK3290528T3 (da) | 2011-09-23 | 2012-09-21 | Fremgangsmåder og sammensætninger til nukleinsyresekventering |
| DK12766838.2T DK2768972T3 (da) | 2011-09-23 | 2012-09-21 | Fremgangsmåder og sammensætninger til nukleinsyresekventering |
| DK19189927.7T DK3623481T3 (da) | 2011-09-23 | 2012-09-21 | Sammensætninger til nukleinsyresekventering |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17180583T DK3290528T3 (da) | 2011-09-23 | 2012-09-21 | Fremgangsmåder og sammensætninger til nukleinsyresekventering |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19189927.7T DK3623481T3 (da) | 2011-09-23 | 2012-09-21 | Sammensætninger til nukleinsyresekventering |
Country Status (15)
| Country | Link |
|---|---|
| US (5) | US9453258B2 (da) |
| EP (4) | EP3290528B1 (da) |
| CA (2) | CA2859660C (da) |
| CY (1) | CY1125261T1 (da) |
| DK (3) | DK3290528T3 (da) |
| ES (3) | ES2752653T3 (da) |
| HR (1) | HRP20211523T1 (da) |
| HU (1) | HUE056246T2 (da) |
| LT (1) | LT3623481T (da) |
| PL (2) | PL3290528T3 (da) |
| PT (2) | PT3290528T (da) |
| RS (1) | RS62530B1 (da) |
| SI (1) | SI3623481T1 (da) |
| SM (1) | SMT202100624T1 (da) |
| WO (1) | WO2013044018A1 (da) |
Families Citing this family (371)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7057026B2 (en) | 2001-12-04 | 2006-06-06 | Solexa Limited | Labelled nucleotides |
| US11008359B2 (en) | 2002-08-23 | 2021-05-18 | Illumina Cambridge Limited | Labelled nucleotides |
| US8178360B2 (en) | 2006-05-18 | 2012-05-15 | Illumina Cambridge Limited | Dye compounds and the use of their labelled conjugates |
| US11940413B2 (en) | 2007-02-05 | 2024-03-26 | IsoPlexis Corporation | Methods and devices for sequencing nucleic acids in smaller batches |
| US9163053B2 (en) * | 2007-05-18 | 2015-10-20 | Fluidigm Corporation | Nucleotide analogs |
| US9017973B2 (en) | 2008-03-19 | 2015-04-28 | Intelligent Biosystems, Inc. | Methods and compositions for incorporating nucleotides |
| US20190300945A1 (en) | 2010-04-05 | 2019-10-03 | Prognosys Biosciences, Inc. | Spatially Encoded Biological Assays |
| US10787701B2 (en) | 2010-04-05 | 2020-09-29 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
| HRP20151294T1 (hr) | 2010-04-05 | 2016-03-11 | Prognosys Biosciences, Inc. | Biološka testiranja sa prostornim kodiranjem |
| EP2632593B1 (en) | 2010-10-27 | 2021-09-29 | Illumina, Inc. | Flow cells for biological or chemical analysis |
| US9387476B2 (en) | 2010-10-27 | 2016-07-12 | Illumina, Inc. | Flow cells for biological or chemical analysis |
| GB201106254D0 (en) | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
| ES2625288T3 (es) | 2011-04-15 | 2017-07-19 | The Johns Hopkins University | Sistema de secuenciación segura |
| CA2859660C (en) * | 2011-09-23 | 2021-02-09 | Illumina, Inc. | Methods and compositions for nucleic acid sequencing |
| EP3222627B1 (en) * | 2012-02-15 | 2019-08-07 | Pacific Biosciences of California, Inc. | Polymerase enzyme substrates with protein shield |
| WO2014060483A1 (en) | 2012-10-17 | 2014-04-24 | Spatial Transcriptomics Ab | Methods and product for optimising localised or spatial detection of gene expression in a tissue sample |
| AU2013338393C1 (en) | 2012-10-29 | 2024-07-25 | The Johns Hopkins University | Papanicolaou test for ovarian and endometrial cancers |
| BR112015022448B1 (pt) | 2013-03-15 | 2020-12-08 | Illumina Cambridge Limited | molécula de nucleotídeo ou nucleosídeo modificado, métodos para preparar o crescimento de polinucleotídeo complementar a polinucleotídeo alvo de fita simples em reação de sequenciação e para determinar a sequência de polinucleotídeo alvo de fita simples e kit |
| EP3013983B1 (en) | 2013-06-25 | 2023-02-15 | Prognosys Biosciences, Inc. | Spatially encoded biological assays using a microfluidic device |
| CA2914248C (en) | 2013-07-03 | 2021-09-07 | Illumina, Inc. | Sequencing by orthogonal synthesis |
| WO2015021228A1 (en) | 2013-08-08 | 2015-02-12 | Illumina, Inc. | Fluidic system for reagent delivery to a flow cell |
| RS60736B1 (sr) | 2013-12-03 | 2020-09-30 | Illumina Inc | Postupci i sistemi za analizu podataka sa slika |
| ES2866044T3 (es) | 2014-02-18 | 2021-10-19 | Illumina Inc | Métodos y composiciones para la elaboración de perfiles de ADN |
| CN106459869B (zh) | 2014-03-11 | 2020-01-21 | 伊鲁米那股份有限公司 | 一次性的集成微流体盒及其制备和使用的方法 |
| US10570447B2 (en) * | 2014-05-16 | 2020-02-25 | Illumina, Inc. | Nucleic acid synthesis techniques |
| CN110038653A (zh) | 2014-05-27 | 2019-07-23 | 伊鲁米那股份有限公司 | 包括基本仪器和可拆卸盒的用于生物化学分析的系统和方法 |
| US20150353989A1 (en) | 2014-06-09 | 2015-12-10 | Illumina Cambridge Limited | Sample preparation for nucleic acid amplification |
| GB201414098D0 (en) * | 2014-08-08 | 2014-09-24 | Illumina Cambridge Ltd | Modified nucleotide linkers |
| WO2016040602A1 (en) | 2014-09-11 | 2016-03-17 | Epicentre Technologies Corporation | Reduced representation bisulfite sequencing using uracil n-glycosylase (ung) and endonuclease iv |
| EP3191606B1 (en) | 2014-09-12 | 2020-05-27 | Illumina, Inc. | Methods for detecting the presence of polymer subunits using chemiluminescence |
| US9897791B2 (en) | 2014-10-16 | 2018-02-20 | Illumina, Inc. | Optical scanning systems for in situ genetic analysis |
| GB201418718D0 (en) * | 2014-10-21 | 2014-12-03 | Cambridge Epigenetix Ltd | Improved nucleic acid re-sequencing using a reduced number of identified bases |
| WO2016065248A1 (en) | 2014-10-23 | 2016-04-28 | Complete Genomics, Inc. | Signal confinement sequencing (scs) and nucleotide analogues for signal confinement sequencing |
| GB201419731D0 (en) | 2014-11-05 | 2014-12-17 | Illumina Cambridge Ltd | Sequencing from multiple primers to increase data rate and density |
| EP3215616B1 (en) | 2014-11-05 | 2019-12-18 | Illumina Cambridge Limited | Reducing dna damage during sample preparation and sequencing using siderophore chelators |
| DK3218511T3 (da) | 2014-11-11 | 2020-07-20 | Illumina Cambridge Ltd | Fremgangsmåder og arrays til frembringelse og sekventering af monoklonale klynger af nukleinsyre |
| CN112782140A (zh) | 2014-12-03 | 2021-05-11 | 伊索普莱西斯公司 | 细胞分泌特征的分析和筛选 |
| WO2016154038A1 (en) | 2015-03-20 | 2016-09-29 | Illumina, Inc. | Fluidics cartridge for use in the vertical or substantially vertical position |
| CN107532205B (zh) | 2015-03-31 | 2021-06-08 | 伊卢米纳剑桥有限公司 | 模板的表面连环化 |
| US10774374B2 (en) | 2015-04-10 | 2020-09-15 | Spatial Transcriptomics AB and Illumina, Inc. | Spatially distinguished, multiplex nucleic acid analysis of biological specimens |
| US10787704B2 (en) | 2015-05-12 | 2020-09-29 | Illumina, Inc. | Field-effect apparatus and methods for sequencing nucleic acids |
| WO2016196358A1 (en) | 2015-05-29 | 2016-12-08 | Epicentre Technologies Corporation | Methods of analyzing nucleic acids |
| ES2789349T3 (es) | 2015-05-29 | 2020-10-26 | Illumina Cambridge Ltd | Utilización mejorada de cebadores de superficie en grupos |
| CN107922966B (zh) | 2015-07-06 | 2022-06-28 | 伊卢米纳剑桥有限公司 | 用于核酸扩增的样品制备 |
| ES2888626T3 (es) | 2015-07-27 | 2022-01-05 | Illumina Inc | Cartografiado espacial de información de secuencia de ácidos nucleicos |
| CN114634976B (zh) | 2015-07-30 | 2025-02-21 | 亿明达股份有限公司 | 核苷酸的正交去封闭 |
| US11286531B2 (en) | 2015-08-11 | 2022-03-29 | The Johns Hopkins University | Assaying ovarian cyst fluid |
| CN105112516A (zh) * | 2015-08-14 | 2015-12-02 | 深圳市瀚海基因生物科技有限公司 | 一种单分子靶向测序方法、装置、系统及应用 |
| SG10202106413SA (en) | 2015-08-14 | 2021-07-29 | Illumina Inc | Systems and methods using magnetically-responsive sensors for determining a genetic characteristic |
| EP3338096B1 (en) | 2015-08-24 | 2024-03-06 | Illumina, Inc. | In-line pressure accumulator and flow-control system for biological or chemical assays |
| EP3356381A4 (en) | 2015-09-28 | 2019-06-12 | The Trustees of Columbia University in the City of New York | DESIGN AND SYNTHESIS OF NUCLEOTIDES BASED ON NOVEL DISULFIDE COMPOUNDS AS REVERSIBLE TERMINATORS FOR DNA SEQUENCING BY SYNTHESIS |
| EP3377113A4 (en) * | 2015-11-18 | 2019-06-19 | Synergy Pharmaceuticals, Inc. | COMPOSITIONS AND METHODS OF TREATMENT AND DETECTION OF CANCER |
| US10059992B2 (en) | 2016-03-24 | 2018-08-28 | Illumina, Inc. | Photonic superlattice-based devices and compositions for use in luminescent imaging, and methods of using the same |
| JP6953430B2 (ja) | 2016-04-22 | 2021-10-27 | イラミーナ インコーポレーテッド | ピクセル内における複数部位の発光性造影に使用するためのフォトニック構造をベースとしたデバイス及び組成物、並びにその使用方法 |
| CN109790196B (zh) * | 2016-04-22 | 2022-09-27 | 深圳华大智造科技股份有限公司 | 可逆封闭的核苷类似物及其用途 |
| US11266673B2 (en) | 2016-05-23 | 2022-03-08 | The Trustees Of Columbia University In The City Of New York | Nucleotide derivatives and methods of use thereof |
| CN117822128A (zh) | 2016-07-22 | 2024-04-05 | 俄勒冈健康与科学大学 | 单细胞全基因组文库及制备其的组合索引方法 |
| KR102230444B1 (ko) | 2016-08-15 | 2021-03-23 | 옴니옴 인코포레이티드 | 핵산을 시퀀싱하기 위한 방법 및 시스템 |
| EP3510398B1 (en) | 2016-09-12 | 2026-02-25 | Isoplexis Corporation | System and methods for multiplexed analysis of cellular and other immunotherapeutics |
| US10385214B2 (en) | 2016-09-30 | 2019-08-20 | Illumina Cambridge Limited | Fluorescent dyes and their uses as biomarkers |
| EP4036578A1 (en) | 2016-11-11 | 2022-08-03 | Isoplexis Corporation | Compositions and methods for the simultaneous genomic, transcriptomic and proteomic analysis of single cells |
| CN110226084A (zh) | 2016-11-22 | 2019-09-10 | 伊索普莱克西斯公司 | 用于细胞捕获的系统、装置和方法，以及其制造方法 |
| EP4257596A3 (en) | 2016-12-22 | 2023-12-06 | Illumina Cambridge Limited | Coumarin compounds and their uses as fluorescent labels |
| EP3564387A4 (en) * | 2016-12-27 | 2020-10-07 | EGI Tech (Shen Zhen) Co., Limited | UNIQUE FLUORESCENT DYE SEQUENCING PROCESS |
| US10851410B2 (en) * | 2017-01-04 | 2020-12-01 | Mgi Tech Co., Ltd. | Nucleic acid sequencing using affinity reagents |
| CN116612818A (zh) | 2017-01-06 | 2023-08-18 | 伊鲁米那股份有限公司 | 移相校正 |
| WO2018136416A1 (en) | 2017-01-17 | 2018-07-26 | Illumina, Inc. | Oncogenic splice variant determination |
| US11896944B2 (en) | 2017-02-01 | 2024-02-13 | Illumina, Inc. | System and method with fiducials responding to multiple excitation frequencies |
| GB201701688D0 (en) | 2017-02-01 | 2017-03-15 | Illumia Inc | System and method with fiducials in non-recliner layouts |
| GB201701689D0 (en) | 2017-02-01 | 2017-03-15 | Illumia Inc | System and method with fiducials of non-closed shapes |
| GB201701686D0 (en) | 2017-02-01 | 2017-03-15 | Illunina Inc | System & method with fiducials having offset layouts |
| CN119639879A (zh) | 2017-03-28 | 2025-03-18 | 哥伦比亚大学董事会 | 用于连接荧光标记与用于dna合成测序的碱基的具有不同可裂解连接子的3'-o-改性的核苷酸类似物 |
| EP3615671B1 (en) | 2017-04-23 | 2021-07-21 | Illumina Cambridge Limited | Compositions and methods for improving sample identification in indexed nucleic acid libraries |
| US10161003B2 (en) | 2017-04-25 | 2018-12-25 | Omniome, Inc. | Methods and apparatus that increase sequencing-by-binding efficiency |
| US9951385B1 (en) * | 2017-04-25 | 2018-04-24 | Omniome, Inc. | Methods and apparatus that increase sequencing-by-binding efficiency |
| FI3981884T3 (fi) | 2017-06-07 | 2023-09-21 | Univ Oregon Health & Science | Yksittäissolujen kokogenomikirjastoja metylaatiosekvensointia varten |
| US11542540B2 (en) * | 2017-06-16 | 2023-01-03 | Life Technologies Corporation | Control nucleic acids, and compositions, kits, and uses thereof |
| EP3642362B1 (en) | 2017-06-20 | 2025-10-15 | Illumina, Inc. | Methods for addressing inefficiencies in amplification reactions |
| CN109207571B (zh) * | 2017-06-30 | 2022-01-04 | 深圳华大生命科学研究院 | 一种检测核酸内切酶酶切位点的方法 |
| WO2019027767A1 (en) | 2017-07-31 | 2019-02-07 | Illumina Inc. | SEQUENCING SYSTEM COMPRISING AGGREGATION OF MULTIPLEXED BIOLOGICAL SAMPLES |
| FI3662083T3 (fi) | 2017-08-01 | 2024-11-20 | Illumina Inc | Geneettisen materiaalin ja kirjastovalmisteen spatiaalinen indeksointi hydrogeelihelmiä ja virtauskennoja käyttämällä |
| IL319255A (en) | 2017-08-07 | 2025-04-01 | Univ Johns Hopkins | Methods and materials for cancer assessment and treatment |
| AU2018359670B2 (en) * | 2017-11-06 | 2021-08-26 | Illumina, Inc. | Nucleic acid indexing techniques |
| NL2020636B1 (en) * | 2017-12-28 | 2019-07-08 | Illumina Inc | Light energy fluorescence excitation |
| US11378544B2 (en) | 2018-01-08 | 2022-07-05 | Illumina, Inc. | High-throughput sequencing with semiconductor-based detection |
| KR102369895B1 (ko) | 2018-01-08 | 2022-03-03 | 일루미나, 인코포레이티드 | 칩-기반 서열분석기를 위한 고-처리율 염기 콜링 |
| WO2019161253A1 (en) | 2018-02-16 | 2019-08-22 | Ultima Genomics, Inc. | Methods for sequencing with single frequency detection |
| US12188086B2 (en) | 2018-03-15 | 2025-01-07 | The Trustees Of Columbia University In The City Of New York | Nucleotide analogues and use thereof for nucleic acid sequencing and analysis preliminary class |
| US12188012B2 (en) | 2018-04-02 | 2025-01-07 | Illumina, Inc. | Compositions and methods for making controls for sequence-based genetic testing |
| CA3097583A1 (en) | 2018-04-19 | 2019-10-24 | Omniome, Inc. | Improving accuracy of base calls in nucleic acid sequencing methods |
| IL271454B2 (en) | 2018-05-17 | 2025-04-01 | Illumina Inc | Rapid single-cell genetic sequencing with low Aggregation bias |
| WO2019231568A1 (en) | 2018-05-31 | 2019-12-05 | Omniome, Inc. | Increased signal to noise in nucleic acid sequencing |
| US11180794B2 (en) | 2018-05-31 | 2021-11-23 | Omniome, Inc. | Methods and compositions for capping nucleic acids |
| CN111247248A (zh) | 2018-06-04 | 2020-06-05 | 伊鲁米纳公司 | 高通量单细胞转录组文库及制备和使用方法 |
| NL2021258B1 (en) | 2018-06-14 | 2019-12-20 | Illumina Inc | Device for luminescent imaging |
| EP3844304B1 (en) | 2018-08-28 | 2024-10-02 | 10X Genomics, Inc. | Methods for generating spatially barcoded arrays |
| EP3844308A1 (en) | 2018-08-28 | 2021-07-07 | 10X Genomics, Inc. | Resolving spatial arrays |
| US11519033B2 (en) | 2018-08-28 | 2022-12-06 | 10X Genomics, Inc. | Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample |
| EP3878968A4 (en) * | 2018-11-07 | 2022-08-17 | EGI Tech (Shen Zhen) Co., Limited | PROCEDURE FOR SEQUENCING POLYNUCLEOTIDS |
| SG11202012762WA (en) | 2018-12-05 | 2021-01-28 | Illumina Cambridge Ltd | Methods and compositions for cluster generation by bridge amplification |
| US12529094B2 (en) | 2018-12-10 | 2026-01-20 | 10X Genomics, Inc. | Imaging system hardware |
| EP3894590B1 (en) | 2018-12-10 | 2025-10-22 | 10X Genomics, Inc. | Methods of using master / copy arrays for spatial detection |
| JP7542444B2 (ja) | 2018-12-14 | 2024-08-30 | イルミナ ケンブリッジ リミテッド | 配列決定の間のアンラベル化ヌクレオチドによるフェージング減少 |
| US11841310B2 (en) * | 2018-12-17 | 2023-12-12 | Illumina, Inc. | Flow cells and sequencing kits |
| ES3032918T3 (en) | 2018-12-17 | 2025-07-28 | Illumina Cambridge Ltd | Method of polynucleotide sequencing |
| WO2020126602A1 (en) | 2018-12-18 | 2020-06-25 | Illumina Cambridge Limited | Methods and compositions for paired end sequencing using a single surface primer |
| US11293061B2 (en) | 2018-12-26 | 2022-04-05 | Illumina Cambridge Limited | Sequencing methods using nucleotides with 3′ AOM blocking group |
| US11926867B2 (en) | 2019-01-06 | 2024-03-12 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
| US11649485B2 (en) | 2019-01-06 | 2023-05-16 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
| US11787930B2 (en) | 2019-01-14 | 2023-10-17 | Illumina Inc. | Flow cell including a heteropolymer |
| EP3702474A1 (en) * | 2019-02-26 | 2020-09-02 | QIAGEN GmbH | Sequencing method and kit |
| CN114174531A (zh) | 2019-02-28 | 2022-03-11 | 10X基因组学有限公司 | 用空间条码化寡核苷酸阵列对生物分析物进行概况分析 |
| WO2020178231A1 (en) | 2019-03-01 | 2020-09-10 | Illumina, Inc. | Multiplexed fluorescent detection of analytes |
| CA3113841A1 (en) | 2019-03-01 | 2020-09-10 | Illumina, Inc. | High-throughput single-nuclei and single-cell libraries and methods of making and of using |
| AU2020230955B2 (en) | 2019-03-01 | 2025-06-05 | Illumina Cambridge Limited | Exocyclic amine-substituted coumarin compounds and their uses as fluorescent labels |
| NL2023327B1 (en) | 2019-03-01 | 2020-09-17 | Illumina Inc | Multiplexed fluorescent detection of analytes |
| WO2020190509A1 (en) | 2019-03-15 | 2020-09-24 | 10X Genomics, Inc. | Methods for using spatial arrays for single cell sequencing |
| US11210554B2 (en) | 2019-03-21 | 2021-12-28 | Illumina, Inc. | Artificial intelligence-based generation of sequencing metadata |
| US11783917B2 (en) | 2019-03-21 | 2023-10-10 | Illumina, Inc. | Artificial intelligence-based base calling |
| WO2020198071A1 (en) | 2019-03-22 | 2020-10-01 | 10X Genomics, Inc. | Three-dimensional spatial analysis |
| US11421271B2 (en) | 2019-03-28 | 2022-08-23 | Illumina Cambridge Limited | Methods and compositions for nucleic acid sequencing using photoswitchable labels |
| EP3941625A1 (en) | 2019-04-12 | 2022-01-26 | Western Digital Technologies Inc. | Nucleic acid sequencing by synthesis using magnetic sensor arrays |
| US11579217B2 (en) | 2019-04-12 | 2023-02-14 | Western Digital Technologies, Inc. | Devices and methods for frequency- and phase-based detection of magnetically-labeled molecules using spin torque oscillator (STO) sensors |
| US11327073B2 (en) | 2019-04-12 | 2022-05-10 | Western Digital Technologies, Inc. | Thermal sensor array for molecule detection and related detection schemes |
| US11112468B2 (en) | 2019-04-12 | 2021-09-07 | Western Digital Technologies, Inc. | Magnetoresistive sensor array for molecule detection and related detection schemes |
| US11609208B2 (en) | 2019-04-12 | 2023-03-21 | Western Digital Technologies, Inc. | Devices and methods for molecule detection based on thermal stabilities of magnetic nanoparticles |
| US11738336B2 (en) | 2019-04-12 | 2023-08-29 | Western Digital Technologies, Inc. | Spin torque oscillator (STO) sensors used in nucleic acid sequencing arrays and detection schemes for nucleic acid sequencing |
| US12565677B2 (en) * | 2019-05-15 | 2026-03-03 | Qingdao MGI Tech Co., Ltd. | Single-channel sequencing method based on self-luminescence |
| US11593649B2 (en) | 2019-05-16 | 2023-02-28 | Illumina, Inc. | Base calling using convolutions |
| AU2020276115A1 (en) | 2019-05-16 | 2021-01-07 | Illumina, Inc. | Systems and devices for characterization and performance analysis of pixel-based sequencing |
| US11423306B2 (en) | 2019-05-16 | 2022-08-23 | Illumina, Inc. | Systems and devices for characterization and performance analysis of pixel-based sequencing |
| EP3976820A1 (en) | 2019-05-30 | 2022-04-06 | 10X Genomics, Inc. | Methods of detecting spatial heterogeneity of a biological sample |
| CN112654719A (zh) | 2019-05-31 | 2021-04-13 | 伊鲁米纳公司 | 使用流动池进行信息存储和检索的系统和方法 |
| WO2020243076A1 (en) | 2019-05-31 | 2020-12-03 | Illumina, Inc. | System and method for storage |
| EP3976827A4 (en) | 2019-05-31 | 2023-10-18 | Illumina, Inc. | Obtaining information from a biological sample in a flow cell |
| CN112673251A (zh) | 2019-05-31 | 2021-04-16 | 伊鲁米那股份有限公司 | 核苷酸选择性沉积或激活的流通池 |
| WO2020243075A1 (en) | 2019-05-31 | 2020-12-03 | Illumina, Inc. | Storage device, system, and method |
| EP3976751A4 (en) | 2019-05-31 | 2023-01-11 | Illumina, Inc. | FLOW CELL WITH ONE OR MORE BARRIER PROPERTIES |
| CN114981283A (zh) * | 2019-07-09 | 2022-08-30 | 纽约市哥伦比亚大学信托人 | 新型核苷酸类似物和使用方法 |
| WO2021031109A1 (zh) * | 2019-08-20 | 2021-02-25 | 深圳华大智造极创科技有限公司 | 一种基于发光标记物光信号动力学及二次发光信号对多核苷酸进行测序的方法 |
| US11208682B2 (en) | 2019-09-13 | 2021-12-28 | Western Digital Technologies, Inc. | Enhanced optical detection for nucleic acid sequencing using thermally-dependent fluorophore tags |
| WO2021091611A1 (en) | 2019-11-08 | 2021-05-14 | 10X Genomics, Inc. | Spatially-tagged analyte capture agents for analyte multiplexing |
| WO2021092433A2 (en) | 2019-11-08 | 2021-05-14 | 10X Genomics, Inc. | Enhancing specificity of analyte binding |
| WO2021102039A1 (en) | 2019-11-21 | 2021-05-27 | 10X Genomics, Inc, | Spatial analysis of analytes |
| US11747329B2 (en) | 2019-11-22 | 2023-09-05 | Western Digital Technologies, Inc. | Magnetic gradient concentrator/reluctance detector for molecule detection |
| EP3927824A2 (en) | 2019-12-19 | 2021-12-29 | Illumina, Inc. | High-throughput single-cell libraries and methods of making and of using |
| CN115135984B (zh) | 2019-12-23 | 2025-12-23 | 10X基因组学有限公司 | 可逆固定试剂及其使用方法 |
| WO2021133849A1 (en) | 2019-12-23 | 2021-07-01 | 10X Genomics, Inc. | Methods for spatial analysis using rna-templated ligation |
| EP4081656A1 (en) | 2019-12-23 | 2022-11-02 | 10X Genomics, Inc. | Compositions and methods for using fixed biological samples in partition-based assays |
| US12365942B2 (en) | 2020-01-13 | 2025-07-22 | 10X Genomics, Inc. | Methods of decreasing background on a spatial array |
| US12405264B2 (en) | 2020-01-17 | 2025-09-02 | 10X Genomics, Inc. | Electrophoretic system and method for analyte capture |
| US11732299B2 (en) | 2020-01-21 | 2023-08-22 | 10X Genomics, Inc. | Spatial assays with perturbed cells |
| US11702693B2 (en) | 2020-01-21 | 2023-07-18 | 10X Genomics, Inc. | Methods for printing cells and generating arrays of barcoded cells |
| US20210230681A1 (en) | 2020-01-24 | 2021-07-29 | 10X Genomics, Inc. | Methods for spatial analysis using proximity ligation |
| US12076701B2 (en) | 2020-01-31 | 2024-09-03 | 10X Genomics, Inc. | Capturing oligonucleotides in spatial transcriptomics |
| US12110541B2 (en) | 2020-02-03 | 2024-10-08 | 10X Genomics, Inc. | Methods for preparing high-resolution spatial arrays |
| US11898205B2 (en) | 2020-02-03 | 2024-02-13 | 10X Genomics, Inc. | Increasing capture efficiency of spatial assays |
| US12112833B2 (en) | 2020-02-04 | 2024-10-08 | 10X Genomics, Inc. | Systems and methods for index hopping filtering |
| US11732300B2 (en) | 2020-02-05 | 2023-08-22 | 10X Genomics, Inc. | Increasing efficiency of spatial analysis in a biological sample |
| WO2021158925A1 (en) | 2020-02-07 | 2021-08-12 | 10X Genomics, Inc. | Quantitative and automated permeabilization performance evaluation for spatial transcriptomics |
| JP2023513606A (ja) | 2020-02-14 | 2023-03-31 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 核酸を評価するための方法および材料 |
| US12281357B1 (en) | 2020-02-14 | 2025-04-22 | 10X Genomics, Inc. | In situ spatial barcoding |
| EP4107284A1 (en) | 2020-02-17 | 2022-12-28 | 10X Genomics, Inc. | In situ analysis of chromatin interaction |
| US12354008B2 (en) | 2020-02-20 | 2025-07-08 | Illumina, Inc. | Knowledge distillation and gradient pruning-based compression of artificial intelligence-based base caller |
| US12591780B2 (en) | 2020-02-20 | 2026-03-31 | Illumina, Inc. | Data compression for artificial intelligence-based base calling |
| CA3168435A1 (en) | 2020-02-20 | 2021-08-26 | Illumina Inc. | Artificial intelligence-based many-to-many base calling |
| US12592298B2 (en) | 2020-02-20 | 2026-03-31 | Illumina, Inc. | Hardware execution and acceleration of artificial intelligence-based base caller |
| EP4484571A3 (en) | 2020-02-21 | 2025-03-19 | 10X Genomics, Inc. | Methods and compositions for integrated in situ spatial assay |
| US11891654B2 (en) | 2020-02-24 | 2024-02-06 | 10X Genomics, Inc. | Methods of making gene expression libraries |
| US12188085B2 (en) | 2020-03-05 | 2025-01-07 | 10X Genomics, Inc. | Three-dimensional spatial transcriptomics with sequencing readout |
| GB2608318A (en) * | 2020-03-13 | 2022-12-28 | Apton Biosystems Inc | Densely-packed analyte layers and detection methods |
| WO2021188717A1 (en) * | 2020-03-18 | 2021-09-23 | Apton Biosystems, Inc. | Systems and methods of detecting densely-packed analytes |
| WO2021216627A1 (en) * | 2020-04-21 | 2021-10-28 | Roche Sequencing Solutions, Inc. | High-throughput nucleic acid sequencing with single-molecule sensor arrays |
| ES2965354T3 (es) | 2020-04-22 | 2024-04-12 | 10X Genomics Inc | Métodos para análisis espacial que usan eliminación de ARN elegido como diana |
| US11188778B1 (en) | 2020-05-05 | 2021-11-30 | Illumina, Inc. | Equalization-based image processing and spatial crosstalk attenuator |
| KR20230035237A (ko) | 2020-05-12 | 2023-03-13 | 일루미나, 인코포레이티드 | 재조합 말단 데옥시뉴클레오티딜 트랜스퍼라제를 사용하여 변형된 염기를 갖는 핵산의 생성 |
| EP4553168A3 (en) | 2020-05-22 | 2025-08-27 | 10x Genomics, Inc. | Spatial analysis to detect sequence variants |
| EP4153775B1 (en) | 2020-05-22 | 2024-07-24 | 10X Genomics, Inc. | Simultaneous spatio-temporal measurement of gene expression and cellular activity |
| WO2021242834A1 (en) | 2020-05-26 | 2021-12-02 | 10X Genomics, Inc. | Method for resetting an array |
| US12031177B1 (en) | 2020-06-04 | 2024-07-09 | 10X Genomics, Inc. | Methods of enhancing spatial resolution of transcripts |
| WO2021252499A1 (en) | 2020-06-08 | 2021-12-16 | 10X Genomics, Inc. | Methods of determining a surgical margin and methods of use thereof |
| WO2021252617A1 (en) | 2020-06-09 | 2021-12-16 | Illumina, Inc. | Methods for increasing yield of sequencing libraries |
| EP4165207B1 (en) | 2020-06-10 | 2024-09-25 | 10X Genomics, Inc. | Methods for determining a location of an analyte in a biological sample |
| IL316161A (en) | 2020-06-22 | 2024-12-01 | Illumina Cambridge Ltd | Nucleotides and nucleosides with a 3' masking group |
| EP4172362B1 (en) | 2020-06-25 | 2024-09-18 | 10X Genomics, Inc. | Spatial analysis of dna methylation |
| AU2021299216A1 (en) | 2020-06-30 | 2022-12-08 | Illumina, Inc. | Catalytically controlled sequencing by synthesis to produce scarless DNA |
| US12168801B1 (en) | 2020-07-02 | 2024-12-17 | 10X Genomics, Inc. | Hybrid/capture probe designs for full-length cDNA |
| US11761038B1 (en) | 2020-07-06 | 2023-09-19 | 10X Genomics, Inc. | Methods for identifying a location of an RNA in a biological sample |
| US11981960B1 (en) | 2020-07-06 | 2024-05-14 | 10X Genomics, Inc. | Spatial analysis utilizing degradable hydrogels |
| US12209280B1 (en) | 2020-07-06 | 2025-01-28 | 10X Genomics, Inc. | Methods of identifying abundance and location of an analyte in a biological sample using second strand synthesis |
| KR20230038145A (ko) | 2020-07-08 | 2023-03-17 | 일루미나, 인코포레이티드 | 트랜스포좀 담체로서의 비드 |
| US11981964B2 (en) | 2020-07-28 | 2024-05-14 | Illumina Cambridge Limited | Substituted coumarin dyes and uses as fluorescent labels |
| WO2022032195A2 (en) | 2020-08-06 | 2022-02-10 | Singular Genomics Systems, Inc. | Spatial sequencing |
| EP4121561A4 (en) | 2020-08-06 | 2024-04-17 | Singular Genomics Systems, Inc. | Methods for in situ transcriptomics and proteomics |
| US11981958B1 (en) | 2020-08-20 | 2024-05-14 | 10X Genomics, Inc. | Methods for spatial analysis using DNA capture |
| US12580044B1 (en) | 2020-09-02 | 2026-03-17 | 10X Genomics, Inc. | Systems and methods for identifying cells that are antigen-specific for an immunogenic feature |
| US11926822B1 (en) | 2020-09-23 | 2024-03-12 | 10X Genomics, Inc. | Three-dimensional spatial analysis |
| EP4200444A4 (en) | 2020-10-30 | 2024-09-25 | Singular Genomics Systems, Inc. | METHODS AND COMPOSITIONS FOR REDUCING NUCLEOTIDE IMPURITIES CONTENT |
| US12071667B2 (en) | 2020-11-04 | 2024-08-27 | 10X Genomics, Inc. | Sequence analysis using meta-stable nucleic acid molecules |
| US11827935B1 (en) | 2020-11-19 | 2023-11-28 | 10X Genomics, Inc. | Methods for spatial analysis using rolling circle amplification and detection probes |
| EP4012046A1 (en) | 2020-12-11 | 2022-06-15 | 10X Genomics, Inc. | Methods and compositions for multimodal in situ analysis |
| GB2602063A (en) * | 2020-12-17 | 2022-06-22 | Sumitomo Chemical Co | Sequencing method |
| US20220195516A1 (en) * | 2020-12-17 | 2022-06-23 | Illumina Cambridge Limited | Methods, systems and compositions for nucleic acid sequencing |
| EP4729631A2 (en) | 2020-12-21 | 2026-04-22 | 10X Genomics, Inc. | Methods, compositions, and systems for capturing probes and/or barcodes |
| US20220195518A1 (en) * | 2020-12-22 | 2022-06-23 | Illumina Cambridge Limited | Methods and compositions for nucleic acid sequencing |
| US12060603B2 (en) | 2021-01-19 | 2024-08-13 | 10X Genomics, Inc. | Methods for internally controlled in situ assays using padlock probes |
| EP4284945B1 (en) | 2021-01-26 | 2024-10-23 | 10X Genomics, Inc. | Nucleic acid analog probes for in situ analysis |
| WO2022187366A1 (en) | 2021-03-03 | 2022-09-09 | 10X Genomics, Inc. | Analyte detection in situ using nucleic acid origami |
| WO2022197754A1 (en) | 2021-03-16 | 2022-09-22 | Illumina Software, Inc. | Neural network parameter quantization for base calling |
| US20220301657A1 (en) | 2021-03-16 | 2022-09-22 | Illumina, Inc. | Tile location and/or cycle based weight set selection for base calling |
| CN117043867B (zh) | 2021-04-02 | 2025-11-28 | 因美纳有限公司 | 用于检测用于测序的核苷酸样品玻片内的气泡的机器学习模型 |
| EP4428246B1 (en) | 2021-04-14 | 2025-12-24 | 10X Genomics, Inc. | Methods of measuring mislocalization of an analyte |
| US20220336057A1 (en) | 2021-04-15 | 2022-10-20 | Illumina, Inc. | Efficient voxelization for deep learning |
| US12217829B2 (en) | 2021-04-15 | 2025-02-04 | Illumina, Inc. | Artificial intelligence-based analysis of protein three-dimensional (3D) structures |
| WO2022235764A1 (en) | 2021-05-05 | 2022-11-10 | Singular Genomics Systems, Inc. | Multiomic analysis device and methods of use thereof |
| EP4320271B1 (en) | 2021-05-06 | 2025-03-19 | 10X Genomics, Inc. | Methods for increasing resolution of spatial analysis |
| BR112023024130A2 (pt) | 2021-05-20 | 2024-01-30 | Illumina Cambridge Ltd | Composições e métodos para sequenciamento por síntese |
| US20220380838A1 (en) | 2021-06-01 | 2022-12-01 | 10X Genomics, Inc. | Methods and compositions for analyte detection and probe resolution |
| WO2022256422A1 (en) | 2021-06-02 | 2022-12-08 | 10X Genomics, Inc. | Sample analysis using asymmetric circularizable probes |
| EP4582555A3 (en) | 2021-06-03 | 2025-10-22 | 10X Genomics, Inc. | Methods, compositions, kits, and systems for enhancing analyte capture for spatial analysis |
| EP4359555A1 (en) | 2021-06-23 | 2024-05-01 | Illumina, Inc. | Compositions, methods, kits, cartridges, and systems for sequencing reagents |
| WO2022271689A1 (en) | 2021-06-25 | 2022-12-29 | Illumina, Inc. | Fiducials for use in registration of a patterned surface |
| WO2022269033A1 (en) | 2021-06-25 | 2022-12-29 | Illumina Cambridge Limited | Linear fourier fiducial |
| WO2023278184A1 (en) * | 2021-06-29 | 2023-01-05 | Illumina, Inc. | Methods and systems to correct crosstalk in illumination emitted from reaction sites |
| JP7809733B2 (ja) | 2021-06-29 | 2026-02-02 | イルミナ インコーポレイテッド | オリゴ配列を使用して訓練された自己学習ベースコーラ |
| IL309308A (en) | 2021-06-29 | 2024-02-01 | Illumina Inc | A signal-to-noise ratio measure for determining nucleotide base reads and base call quality |
| WO2023278966A1 (en) | 2021-06-29 | 2023-01-05 | Illumina, Inc. | Machine-learning model for generating confidence classifications for genomic coordinates |
| US12530882B2 (en) | 2021-07-01 | 2026-01-20 | Illumina, Inc. | Efficient artificial intelligence-based base calling of index sequences |
| US12423815B2 (en) | 2021-07-13 | 2025-09-23 | Illumina, Inc. | Methods and systems for real time extraction of crosstalk in illumination emitted from reaction sites |
| CN117651855A (zh) | 2021-07-13 | 2024-03-05 | 10X基因组学有限公司 | 用于制备具有可控厚度的聚合基质的方法 |
| KR20240031968A (ko) | 2021-07-19 | 2024-03-08 | 일루미나, 인코포레이티드 | 염기 호출에 대한 보간 및 적응을 갖는 강도 추출 |
| US11455487B1 (en) | 2021-10-26 | 2022-09-27 | Illumina Software, Inc. | Intensity extraction and crosstalk attenuation using interpolation and adaptation for base calling |
| US20230021577A1 (en) | 2021-07-23 | 2023-01-26 | Illumina Software, Inc. | Machine-learning model for recalibrating nucleotide-base calls |
| EP4377960A1 (en) | 2021-07-28 | 2024-06-05 | Illumina, Inc. | Quality score calibration of basecalling systems |
| US12139751B2 (en) | 2021-07-30 | 2024-11-12 | 10X Genomics, Inc. | Circularizable probes for in situ analysis |
| CA3224093A1 (en) | 2021-07-30 | 2023-02-02 | Jorge Ivan Hernandez Neuta | Methods and compositions for synchronizing reactions in situ |
| US12460251B2 (en) | 2021-08-03 | 2025-11-04 | 10X Genomics, Inc. | Stabilization and/or compaction of nucleic acid molecules |
| EP4381095A1 (en) | 2021-08-03 | 2024-06-12 | 10X Genomics, Inc. | Nucleic acid concatemers and methods for stabilizing and/or compacting the same |
| US12391984B2 (en) | 2021-08-03 | 2025-08-19 | 10X Genomics, Inc. | Compositions and methods for rolling circle amplification |
| US12529096B2 (en) | 2021-08-03 | 2026-01-20 | 10X Genomics, Inc. | Stabilization and/or compaction of nucleic acid structures |
| WO2023014741A1 (en) | 2021-08-03 | 2023-02-09 | Illumina Software, Inc. | Base calling using multiple base caller models |
| US12435364B2 (en) | 2021-08-16 | 2025-10-07 | 10X Genomics, Inc. | Probes comprising a split barcode region and methods of use |
| JP2024534741A (ja) | 2021-09-01 | 2024-09-26 | イルミナ インコーポレイテッド | 加速した塩基呼び出しのための振幅変調 |
| ES3011462T3 (en) | 2021-09-01 | 2025-04-07 | 10X Genomics Inc | Methods for blocking a capture probe on a spatial array |
| JP2024535663A (ja) | 2021-09-17 | 2024-10-02 | イルミナ インコーポレイテッド | ヌクレオチド配列決定における塩基コールエラーパターンからの障害ソースの自動的特定 |
| US20230095961A1 (en) | 2021-09-21 | 2023-03-30 | Illumina, Inc. | Graph reference genome and base-calling approach using imputed haplotypes |
| US12480157B2 (en) | 2021-09-30 | 2025-11-25 | Illumina, Inc. | Polynucleotide sequencing |
| WO2023086880A1 (en) | 2021-11-10 | 2023-05-19 | 10X Genomics, Inc. | Methods, compositions, and kits for determining the location of an analyte in a biological sample |
| EP4305195A2 (en) | 2021-12-01 | 2024-01-17 | 10X Genomics, Inc. | Methods, compositions, and systems for improved in situ detection of analytes and spatial analysis |
| US20230343415A1 (en) | 2021-12-02 | 2023-10-26 | Illumina Software, Inc. | Generating cluster-specific-signal corrections for determining nucleotide-base calls |
| US20230183799A1 (en) | 2021-12-10 | 2023-06-15 | Illumina, Inc. | Parallel sample and index sequencing |
| US20230215515A1 (en) | 2021-12-23 | 2023-07-06 | Illumina Software, Inc. | Facilitating secure execution of external workflows for genomic sequencing diagnostics |
| WO2023122363A1 (en) | 2021-12-23 | 2023-06-29 | Illumina Software, Inc. | Dynamic graphical status summaries for nucelotide sequencing |
| WO2023129898A2 (en) | 2021-12-27 | 2023-07-06 | 10X Genomics, Inc. | Methods and compositions for rolling circle amplification |
| US20230207050A1 (en) | 2021-12-28 | 2023-06-29 | Illumina Software, Inc. | Machine learning model for recalibrating nucleotide base calls corresponding to target variants |
| CA3242624A1 (en) | 2021-12-29 | 2023-07-06 | Shannon Whitmore | Automatically switching variant analysis model versions for genomic analysis applications |
| EP4733410A2 (en) | 2022-01-21 | 2026-04-29 | 10X Genomics, Inc. | Multiple readout signals for analyzing a sample |
| WO2023164570A1 (en) | 2022-02-23 | 2023-08-31 | Insitro, Inc. | Pooled optical screening and transcriptional measurements of cells comprising barcoded genetic perturbations |
| EP4483372B1 (en) | 2022-02-25 | 2026-04-01 | Illumina, Inc. | Calibration sequences for nucelotide sequencing |
| CA3224595A1 (en) | 2022-02-25 | 2023-08-31 | Steven Norberg | Machine-learning models for detecting and adjusting values for nucleotide methylation levels |
| EP4494151A1 (en) | 2022-03-15 | 2025-01-22 | Illumina, Inc. | Methods of determining sequence information |
| CA3223669A1 (en) | 2022-03-15 | 2023-09-21 | Niall Gormley | Concurrent sequencing of forward and reverse complement strands on concatenated polynucleotides for methylation detection |
| US20230304086A1 (en) * | 2022-03-28 | 2023-09-28 | Illumina Cambridge Limited | Labeled avidin and methods for sequencing |
| EP4499872B1 (en) | 2022-03-29 | 2026-04-29 | Illumina, Inc. | Systems and methods of sequencing polynucleotides |
| AU2023243205A1 (en) | 2022-04-01 | 2024-09-19 | 10X Genomics, Inc. | Compositions and methods for targeted masking of autofluorescence |
| CN119234045A (zh) | 2022-04-06 | 2024-12-31 | 10X基因组学有限公司 | 用于多重细胞分析的方法 |
| CN119053701A (zh) | 2022-04-07 | 2024-11-29 | 因美纳有限公司 | 经改变的胞苷脱氨酶和使用方法 |
| EP4515547A1 (en) | 2022-04-26 | 2025-03-05 | Illumina, Inc. | Machine-learning models for selecting oligonucleotide probes for array technologies |
| US20230348967A1 (en) | 2022-04-29 | 2023-11-02 | Illumina Cambridge Limited | Methods and systems for encapsulating lyophilised microspheres |
| WO2023215612A1 (en) | 2022-05-06 | 2023-11-09 | 10X Genomics, Inc. | Analysis of antigen and antigen receptor interactions |
| US20230368866A1 (en) | 2022-05-10 | 2023-11-16 | Illumina Software, Inc. | Adaptive neural network for nucelotide sequencing |
| CN119213143A (zh) | 2022-05-11 | 2024-12-27 | 10X基因组学有限公司 | 用于原位测序的组合物和方法 |
| CA3251383A1 (en) | 2022-05-31 | 2023-12-07 | Illumina, Inc | NUCLEIC ACID COMPOSITIONS AND SEQUENCE METHODS |
| WO2023245190A1 (en) | 2022-06-17 | 2023-12-21 | 10X Genomics, Inc. | Catalytic de-crosslinking of samples for in situ analysis |
| EP4544558A1 (en) | 2022-06-24 | 2025-04-30 | Illumina, Inc. | Improving split-read alignment by intelligently identifying and scoring candidate split groups |
| CN119422199A (zh) | 2022-06-27 | 2025-02-11 | 因美纳有限公司 | 用于基因型推算模型的加速器 |
| WO2024006769A1 (en) | 2022-06-27 | 2024-01-04 | Illumina Software, Inc. | Generating and implementing a structural variation graph genome |
| WO2024006705A1 (en) | 2022-06-27 | 2024-01-04 | Illumina Software, Inc. | Improved human leukocyte antigen (hla) genotyping |
| US20240038327A1 (en) | 2022-07-26 | 2024-02-01 | Illumina Software, Inc. | Rapid single-cell multiomics processing using an executable file |
| US20240033738A1 (en) | 2022-07-27 | 2024-02-01 | Illumina, Inc. | Flow cell based motion system calibration and control methods |
| CN119677856A (zh) | 2022-08-12 | 2025-03-21 | 10X基因组学有限公司 | Puma1聚合酶及其用途 |
| JP2025528823A (ja) | 2022-08-15 | 2025-09-02 | エレメント バイオサイエンシズ，インコーポレイティド | コンパクト化オリゴヌクレオチドを使用して核酸ナノ構造を調製するための方法 |
| WO2024040060A1 (en) | 2022-08-16 | 2024-02-22 | 10X Genomics, Inc. | Ap50 polymerases and uses thereof |
| US20250361558A1 (en) | 2022-08-19 | 2025-11-27 | Illumina, Inc. | Third dna base pair site-specific dna detection |
| WO2024059852A1 (en) | 2022-09-16 | 2024-03-21 | Illumina, Inc. | Cluster segmentation and conditional base calling |
| WO2024061799A1 (en) | 2022-09-19 | 2024-03-28 | Illumina, Inc. | Deformable polymers comprising immobilised primers |
| EP4594012A1 (en) | 2022-09-26 | 2025-08-06 | Illumina, Inc. | Flow cell based motion system calibration and control methods |
| CN118974830A (zh) | 2022-09-29 | 2024-11-15 | 因美纳有限公司 | 用于推算靶变体的靶变体参考组 |
| JP2025534192A (ja) | 2022-09-30 | 2025-10-15 | イルミナ インコーポレイテッド | 構造バリアントコールを精緻化するための機械学習モデル |
| WO2024073043A1 (en) | 2022-09-30 | 2024-04-04 | Illumina, Inc. | Methods of using cpg binding proteins in mapping modified cytosine nucleotides |
| WO2024073047A1 (en) | 2022-09-30 | 2024-04-04 | Illumina, Inc. | Cytidine deaminases and methods of use in mapping modified cytosine nucleotides |
| EP4594481A1 (en) | 2022-09-30 | 2025-08-06 | Illumina, Inc. | Helicase-cytidine deaminase complexes and methods of use |
| CA3246518A1 (en) | 2022-09-30 | 2024-04-04 | Illumina, Inc. | Compositions and methods for reducing photolesions during sequencing |
| EP4599449A1 (en) | 2022-10-05 | 2025-08-13 | Illumina, Inc. | Integrating variant calls from multiple sequencing pipelines utilizing a machine learning architecture |
| WO2024081649A1 (en) | 2022-10-11 | 2024-04-18 | Illumina, Inc. | Detecting and correcting methylation values from methylation sequencing assays |
| EP4602344A1 (en) | 2022-10-14 | 2025-08-20 | 10X Genomics, Inc. | Methods for analysis of biological samples |
| WO2024102736A1 (en) | 2022-11-08 | 2024-05-16 | 10X Genomics, Inc. | Immobilization methods and compositions for in situ detection |
| WO2024102809A1 (en) | 2022-11-09 | 2024-05-16 | 10X Genomics, Inc. | Methods, compositions, and kits for determining the location of multiple analytes in a biological sample |
| US20240158852A1 (en) | 2022-11-16 | 2024-05-16 | 10X Genomics, Inc. | Methods and compositions for assessing performance of in situ assays |
| US12372771B2 (en) | 2022-11-18 | 2025-07-29 | 10X Genomics, Inc. | Systems and methods for actively mitigating vibrations |
| US12581050B2 (en) | 2022-11-23 | 2026-03-17 | 10X Genomics, Inc. | Optical assemblies for machine vision calibration |
| WO2024118791A1 (en) | 2022-11-30 | 2024-06-06 | Illumina, Inc. | Accurately predicting variants from methylation sequencing data |
| WO2024130203A1 (en) | 2022-12-16 | 2024-06-20 | 10X Genomics, Inc. | Methods and compositions for assessing performance |
| WO2024137860A1 (en) | 2022-12-21 | 2024-06-27 | 10X Genomics, Inc. | Methods for tethering ribonucleic acids in biological samples |
| EP4639552A1 (en) | 2022-12-21 | 2025-10-29 | Illumina, Inc. | Context-dependent base calling |
| EP4638795A1 (en) | 2022-12-22 | 2025-10-29 | Illumina, Inc. | Transition-metal catalyst compositions and methods for sequencing by synthesis |
| CA3246545A1 (en) | 2022-12-22 | 2024-06-27 | Illumina, Inc. | PALLADIUM CATALYST COMPOSITIONS AND SYNTHETIC SEQUENCE PROCESSES |
| CN119095984A (zh) | 2022-12-27 | 2024-12-06 | 伊路米纳有限公司 | 使用3'烯丙基封端的核苷酸的测序方法 |
| EP4646492A1 (en) | 2023-01-06 | 2025-11-12 | 10X Genomics, Inc. | Methods and compositions for in situ analysis of variant sequences |
| WO2024167954A1 (en) | 2023-02-06 | 2024-08-15 | Illumina, Inc. | Determining and removing inter-cluster light interference |
| CN119452101A (zh) | 2023-03-30 | 2025-02-14 | 因美纳公司 | 用于核酸测序的组合物和方法 |
| WO2024206848A1 (en) | 2023-03-30 | 2024-10-03 | Illumina, Inc. | Tandem repeat genotyping |
| WO2024216163A1 (en) * | 2023-04-13 | 2024-10-17 | Esbiolab Llc | Methods and compositions for nucleic acid sequencing using predominantly unlabeled nucleotides |
| WO2024216159A1 (en) * | 2023-04-13 | 2024-10-17 | Esbiolab Llc | Methods and compositions for nucleic acid sequencing using labeled nucleotides |
| US20240368678A1 (en) | 2023-05-03 | 2024-11-07 | 10X Genomics, Inc. | Methods and compositions for spatial assay |
| CN119744419A (zh) | 2023-05-03 | 2025-04-01 | 因美纳有限公司 | 用于重新校准来自现有测序数据文件的基因型检出的机器学习模型 |
| WO2024249200A1 (en) | 2023-05-26 | 2024-12-05 | Illumina, Inc. | Methods for preserving methylation status during clustering |
| WO2024249940A1 (en) | 2023-05-31 | 2024-12-05 | Illumina, Inc. | Improving structural variant alignment and variant calling by utilizing a structural-variant reference genome |
| EP4720332A1 (en) | 2023-06-01 | 2026-04-08 | Singular Genomics Systems, Inc. | Methods and probes for detecting polynucleotide sequences in cells and tissues |
| WO2024249973A2 (en) | 2023-06-02 | 2024-12-05 | Illumina, Inc. | Linking human genes to clinical phenotypes using graph neural networks |
| WO2024256580A1 (en) | 2023-06-14 | 2024-12-19 | Illumina, Inc. | Concurrent sequencing with spatially separated rings |
| EP4728092A1 (en) | 2023-06-14 | 2026-04-22 | Illumina, Inc. | Determination of modified cytosines |
| CN121359206A (zh) | 2023-06-27 | 2026-01-16 | 因美纳有限公司 | 使用甲基化水平估计的变体检出 |
| WO2025006460A1 (en) * | 2023-06-30 | 2025-01-02 | Illumina, Inc. | Systems and methods of sequencing polynucleotides with modified bases |
| WO2025006874A1 (en) | 2023-06-30 | 2025-01-02 | Illumina, Inc. | Machine-learning model for recalibrating genotype calls corresponding to germline variants and somatic mosaic variants |
| WO2025029831A1 (en) | 2023-07-31 | 2025-02-06 | 10X Genomics, Inc. | Methods and systems for targeted rna cleavage and target rna-primed rolling circle amplification |
| WO2025054389A1 (en) | 2023-09-07 | 2025-03-13 | Illumina, Inc. | Identification of methylated cytosine using landmarks |
| AU2023464289A1 (en) | 2023-09-08 | 2026-03-12 | The Regents Of The University Of Michigan | MICRORNA-DERIVED RNAs AND POLYPEPTIDES AND USES THEREOF |
| WO2025061942A1 (en) | 2023-09-20 | 2025-03-27 | Illumina, Inc. | Sequencing error identification and correction |
| WO2025062001A1 (en) | 2023-09-20 | 2025-03-27 | Illumina, Inc. | Optimised nucleic acid sequencing |
| WO2025061922A1 (en) | 2023-09-20 | 2025-03-27 | Illumina, Inc. | Methods for sequencing |
| WO2025062002A1 (en) | 2023-09-20 | 2025-03-27 | Illumina, Inc. | Concurrent sequencing using nick translation |
| WO2025072793A1 (en) | 2023-09-28 | 2025-04-03 | Illumina, Inc. | Altered cytidine deaminases and methods of use |
| WO2025072870A1 (en) | 2023-09-29 | 2025-04-03 | Illumina, Inc. | Tracking and modifying cluster location on nucleotide-sample slides in real time |
| US20250111899A1 (en) | 2023-09-29 | 2025-04-03 | Illumina, Inc. | Predicting insert lengths using primary analysis metrics |
| WO2025081064A2 (en) | 2023-10-11 | 2025-04-17 | Illumina, Inc. | Thermophilic deaminase and methods for identifying modified cytosine |
| WO2025090883A1 (en) | 2023-10-27 | 2025-05-01 | Illumina, Inc. | Detecting variants in nucleotide sequences based on haplotype diversity |
| US20250163502A1 (en) | 2023-11-22 | 2025-05-22 | 10X Genomics, Inc. | Methods for processing ribonucleic acids in biological samples |
| US20250201342A1 (en) | 2023-12-15 | 2025-06-19 | Illumina, Inc. | Minimal residual disease (mrd) models for determining likelihoods or probabilities of a subject comprising cancer |
| US20250201346A1 (en) | 2023-12-18 | 2025-06-19 | Illumina, Inc. | Using machine learning models for detecting minimum residual disease (mrd) in a subject |
| WO2025137222A1 (en) | 2023-12-19 | 2025-06-26 | Illumina, Inc. | Methylation detection assay |
| WO2025137341A1 (en) | 2023-12-20 | 2025-06-26 | Illumina, Inc. | Directly determining signal-to-noise-ratio metrics for accelerated convergence in determining nucleotide-base calls and base-call quality |
| US20250207203A1 (en) | 2023-12-20 | 2025-06-26 | 10X Genomics, Inc. | In situ detection of copy number variations in biological samples |
| US20250210141A1 (en) | 2023-12-21 | 2025-06-26 | Illumina, Inc. | Enhanced mapping and alignment of nucleotide reads utilizing an improved haplotype data structure with allele-variant differences |
| US20250215491A1 (en) | 2023-12-28 | 2025-07-03 | Illumina, Inc. | Sequencing with single-stranded binding proteins |
| US20250215493A1 (en) | 2023-12-28 | 2025-07-03 | Illumina, Inc. | Nucleotides with enzymatically cleavable 3'-o-glycoside blocking groups for sequencing |
| WO2025160089A1 (en) | 2024-01-26 | 2025-07-31 | Illumina, Inc. | Custom multigenome reference construction for improved sequencing analysis of genomic samples |
| WO2025174774A1 (en) | 2024-02-12 | 2025-08-21 | Illumina, Inc. | Determining offline corrections for sequence specific errors caused by low complexity nucleotide sequences |
| WO2025174708A1 (en) | 2024-02-13 | 2025-08-21 | Illumina, Inc. | Design and method for cross-sequencing platform compatibility of flow cells |
| CN121359209A (zh) | 2024-02-28 | 2026-01-16 | 因美纳有限公司 | 用于改进核苷酸读段的映射和比对以及改进基因型检出的个性化单倍型数据库 |
| WO2025184226A1 (en) | 2024-02-28 | 2025-09-04 | Illumina, Inc. | Nucleotides with terminal phosphate capping |
| WO2025188906A1 (en) | 2024-03-08 | 2025-09-12 | Illumina, Inc. | Modified adenosine nucleotides |
| WO2025193747A1 (en) | 2024-03-12 | 2025-09-18 | Illumina, Inc. | Machine-learning models for ordering and expediting sequencing tasks or corresponding nucleotide-sample slides |
| WO2025190902A1 (en) | 2024-03-13 | 2025-09-18 | Illumina, Inc. | Improving base calling quality scores |
| US20250288988A1 (en) | 2024-03-15 | 2025-09-18 | 10X Genomics, Inc. | Systems and methods for covering and sealing an open well |
| WO2025230914A1 (en) | 2024-04-29 | 2025-11-06 | Illumina, Inc. | Nucleotides with enzyme-triggered self-immolative linkers for sequencing by synthesis |
| WO2025240241A1 (en) | 2024-05-13 | 2025-11-20 | Illumina, Inc. | Modifying sequencing cycles during a sequencing run to meet customized coverage estimations for a target genomic region |
| WO2025240924A1 (en) | 2024-05-17 | 2025-11-20 | Illumina, Inc. | Blind equalization systems for base calling applications |
| WO2025240918A1 (en) | 2024-05-17 | 2025-11-20 | 10X Genomics, Inc. | Systems and methods for generating codebooks |
| WO2025250996A2 (en) | 2024-05-31 | 2025-12-04 | Illumina, Inc. | Call generation and recalibration models for implementing personalized diploid reference haplotypes in genotype calling |
| WO2025255457A1 (en) | 2024-06-07 | 2025-12-11 | 10X Genomics, Inc. | Compositions and methods for improved on-target spatial profiling |
| WO2025264702A1 (en) | 2024-06-18 | 2025-12-26 | 10X Genomics, Inc. | 3d hydrogels for nucleic acid sequencing |
| WO2026000160A1 (zh) * | 2024-06-25 | 2026-01-02 | 深圳华大智造科技股份有限公司 | 修饰的染料及其应用 |
| WO2026006746A2 (en) | 2024-06-28 | 2026-01-02 | Illumina, Inc. | Nucleic acid preparation and analysis techniques |
| WO2026006774A1 (en) | 2024-06-28 | 2026-01-02 | Illumina, Inc. | Altered cytidine deaminases and methods of use |
| WO2026006771A1 (en) | 2024-06-28 | 2026-01-02 | Illumina, Inc. | Cluster-filtering scores |
| WO2026030370A1 (en) | 2024-07-30 | 2026-02-05 | Illumina, Inc. | Generating adaptive intensity value decision boundaries for nucleotide sequencing |
| WO2026030369A1 (en) | 2024-07-31 | 2026-02-05 | 10X Genomics, Inc. | Methods and compositions for in situ analyte detection |
| WO2026043885A1 (en) | 2024-08-20 | 2026-02-26 | 10X Genomics, Inc. | Methods and systems for preparing a nucleic acid library |
| WO2026072725A1 (en) | 2024-09-25 | 2026-04-02 | Illumina, Inc. | Adjusting oligonucleotide-cluster location in images in real time using band-edge spectral regions |
| WO2026072986A1 (en) | 2024-09-27 | 2026-04-02 | Illumina, Inc. | Determining offline corrections for sequence specific errors caused by low complexity sequences using a machine learning model |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US781650A (en) | 1904-08-15 | 1905-02-07 | William Heap | Commutator-brush holder. |
| US6051380A (en) | 1993-11-01 | 2000-04-18 | Nanogen, Inc. | Methods and procedures for molecular biological analysis and diagnostics |
| US5641658A (en) | 1994-08-03 | 1997-06-24 | Mosaic Technologies, Inc. | Method for performing amplification of nucleic acid with two primers bound to a single solid support |
| US5695934A (en) | 1994-10-13 | 1997-12-09 | Lynx Therapeutics, Inc. | Massively parallel sequencing of sorted polynucleotides |
| US20020055100A1 (en) | 1997-04-01 | 2002-05-09 | Kawashima Eric H. | Method of nucleic acid sequencing |
| JP2002503954A (ja) | 1997-04-01 | 2002-02-05 | グラクソ、グループ、リミテッド | 核酸増幅法 |
| US5888737A (en) | 1997-04-15 | 1999-03-30 | Lynx Therapeutics, Inc. | Adaptor-based sequence analysis |
| JP2002508664A (ja) | 1997-06-25 | 2002-03-19 | オーキッド・バイオサイエンシーズ・インコーポレイテッド | 複数の単一ヌクレオチド多型を単一の反応で検出する方法 |
| JP4298912B2 (ja) | 1997-07-07 | 2009-07-22 | メディカル リサーチ カウンシル | ｉｎｖｉｔｒｏ選別法 |
| JP3662850B2 (ja) | 1998-06-24 | 2005-06-22 | イルミナ インコーポレイテッド | 微小球を有するアレイセンサーのデコード |
| AR021833A1 (es) | 1998-09-30 | 2002-08-07 | Applied Research Systems | Metodos de amplificacion y secuenciacion de acido nucleico |
| US7071324B2 (en) | 1998-10-13 | 2006-07-04 | Brown University Research Foundation | Systems and methods for sequencing by hybridization |
| NO986133D0 (no) | 1998-12-23 | 1998-12-23 | Preben Lexow | FremgangsmÕte for DNA-sekvensering |
| US6818395B1 (en) * | 1999-06-28 | 2004-11-16 | California Institute Of Technology | Methods and apparatus for analyzing polynucleotide sequences |
| WO2001023610A2 (en) * | 1999-09-29 | 2001-04-05 | Solexa Ltd. | Polynucleotide sequencing |
| AR031640A1 (es) | 2000-12-08 | 2003-09-24 | Applied Research Systems | Amplificacion isotermica de acidos nucleicos en un soporte solido |
| EP1368497A4 (en) * | 2001-03-12 | 2007-08-15 | California Inst Of Techn | METHODS AND APPARATUS FOR ANALYZING ASYNCHRONOUS BASE EXTENSION POLYNUCLEOTIDE SEQUENCES |
| GB0127564D0 (en) | 2001-11-16 | 2002-01-09 | Medical Res Council | Emulsion compositions |
| GB0129012D0 (en) | 2001-12-04 | 2002-01-23 | Solexa Ltd | Labelled nucleotides |
| US20040002090A1 (en) | 2002-03-05 | 2004-01-01 | Pascal Mayer | Methods for detecting genome-wide sequence variations associated with a phenotype |
| WO2003087302A2 (en) * | 2002-04-12 | 2003-10-23 | Stratagene | Dual-labeled nucleotides |
| EP3002289B1 (en) * | 2002-08-23 | 2018-02-28 | Illumina Cambridge Limited | Modified nucleotides for polynucleotide sequencing |
| ES2864086T3 (es) | 2002-08-23 | 2021-10-13 | Illumina Cambridge Ltd | Nucleótidos etiquetados |
| US7414116B2 (en) * | 2002-08-23 | 2008-08-19 | Illumina Cambridge Limited | Labelled nucleotides |
| WO2005003375A2 (en) | 2003-01-29 | 2005-01-13 | 454 Corporation | Methods of amplifying and sequencing nucleic acids |
| US20050181394A1 (en) | 2003-06-20 | 2005-08-18 | Illumina, Inc. | Methods and compositions for whole genome amplification and genotyping |
| EP1641809B2 (en) | 2003-07-05 | 2018-10-03 | The Johns Hopkins University | Method and compositions for detection and enumeration of genetic variations |
| GB0324456D0 (en) * | 2003-10-20 | 2003-11-19 | Isis Innovation | Parallel DNA sequencing methods |
| US7276338B2 (en) | 2003-11-17 | 2007-10-02 | Jacobson Joseph M | Nucleotide sequencing via repetitive single molecule hybridization |
| EP1740100B8 (en) | 2004-04-13 | 2017-01-25 | Biosearch Technologies, Inc. | Xanthene dyes |
| JP2008526877A (ja) * | 2005-01-05 | 2008-07-24 | エージェンコート パーソナル ジェノミクス | 可逆的ヌクレオチドターミネーターおよびその使用 |
| GB0507835D0 (en) | 2005-04-18 | 2005-05-25 | Solexa Ltd | Method and device for nucleic acid sequencing using a planar wave guide |
| JP5331476B2 (ja) | 2005-06-15 | 2013-10-30 | カリダ・ジェノミックス・インコーポレイテッド | 遺伝子解析および化学解析用の単分子アレイ |
| US20060287833A1 (en) | 2005-06-17 | 2006-12-21 | Zohar Yakhini | Method and system for sequencing nucleic acid molecules using sequencing by hybridization and comparison with decoration patterns |
| US7514952B2 (en) | 2005-06-29 | 2009-04-07 | Altera Corporation | I/O circuitry for reducing ground bounce and VCC sag in integrated circuit devices |
| GB0517097D0 (en) * | 2005-08-19 | 2005-09-28 | Solexa Ltd | Modified nucleosides and nucleotides and uses thereof |
| GB0522310D0 (en) | 2005-11-01 | 2005-12-07 | Solexa Ltd | Methods of preparing libraries of template polynucleotides |
| SG170028A1 (en) | 2006-02-24 | 2011-04-29 | Callida Genomics Inc | High throughput genome sequencing on dna arrays |
| CA2643700A1 (en) | 2006-02-24 | 2007-11-22 | Callida Genomics, Inc. | High throughput genome sequencing on dna arrays |
| WO2007107710A1 (en) | 2006-03-17 | 2007-09-27 | Solexa Limited | Isothermal methods for creating clonal single molecule arrays |
| EP3722409A1 (en) | 2006-03-31 | 2020-10-14 | Illumina, Inc. | Systems and devices for sequence by synthesis analysis |
| US8178360B2 (en) | 2006-05-18 | 2012-05-15 | Illumina Cambridge Limited | Dye compounds and the use of their labelled conjugates |
| CA2656525A1 (en) * | 2006-06-30 | 2008-01-10 | Applera Corporation | Reversible terminator nucleotides and methods of use |
| EP2074133A2 (de) * | 2006-09-20 | 2009-07-01 | Genovoxx GmbH | Komponenten und verfahren zur enzymatischen synthese von nukleinsäuren |
| US8399188B2 (en) * | 2006-09-28 | 2013-03-19 | Illumina, Inc. | Compositions and methods for nucleotide sequencing |
| WO2008070352A2 (en) | 2006-10-27 | 2008-06-12 | Complete Genomics, Inc. | Efficient arrays of amplified polynucleotides |
| US7835871B2 (en) * | 2007-01-26 | 2010-11-16 | Illumina, Inc. | Nucleic acid sequencing system and method |
| WO2009051807A1 (en) * | 2007-10-19 | 2009-04-23 | The Trustees Of Columbia University In The City Of New York | Design and synthesis of cleavable fluorescent nucleotides as reversible terminators for dna sequencing by synthesis |
| DK2725107T3 (da) * | 2007-10-19 | 2019-01-02 | Univ Columbia | DNA-sekventering med ikke-fluorescerende nukleotidreversible terminatorer og ddNTP'er modificeret med spaltbart mærke og nukleinsyre omfattende inosin med reversible terminatorer |
| WO2009097368A2 (en) * | 2008-01-28 | 2009-08-06 | Complete Genomics, Inc. | Methods and compositions for efficient base calling in sequencing reactions |
| US8652781B2 (en) * | 2008-02-12 | 2014-02-18 | Pacific Biosciences Of California, Inc. | Cognate sampling kinetics |
| US7771903B2 (en) | 2008-05-28 | 2010-08-10 | Promos Technologies Pte. Ltd. | Photolithography with optical masks having more transparent features surrounded by less transparent features |
| US20100092960A1 (en) | 2008-07-25 | 2010-04-15 | Pacific Biosciences Of California, Inc. | Helicase-assisted sequencing with molecular beacons |
| US8772473B2 (en) * | 2009-03-30 | 2014-07-08 | The Regents Of The University Of California | Mostly natural DNA sequencing by synthesis |
| CN101570784B (zh) * | 2009-06-03 | 2011-11-23 | 东南大学 | 基于信号组合编码的dna连接测序方法 |
| CN101565746B (zh) * | 2009-06-03 | 2012-08-08 | 东南大学 | 带奇偶校验的信号组合编码dna连接测序方法 |
| US9309569B2 (en) * | 2010-08-26 | 2016-04-12 | Intelligent Bio-Systems, Inc. | Methods and compositions for sequencing nucleic acid using charge |
| CA2859660C (en) * | 2011-09-23 | 2021-02-09 | Illumina, Inc. | Methods and compositions for nucleic acid sequencing |
| EP2844774B1 (en) | 2012-05-02 | 2018-07-18 | Ibis Biosciences, Inc. | Dna sequencing |
-
2012
- 2012-09-21 CA CA2859660A patent/CA2859660C/en active Active
- 2012-09-21 US US13/624,200 patent/US9453258B2/en active Active
- 2012-09-21 EP EP17180583.1A patent/EP3290528B1/en active Active
- 2012-09-21 PL PL17180583T patent/PL3290528T3/pl unknown
- 2012-09-21 RS RS20211322A patent/RS62530B1/sr unknown
- 2012-09-21 EP EP19189927.7A patent/EP3623481B1/en active Active
- 2012-09-21 CA CA3104322A patent/CA3104322C/en active Active
- 2012-09-21 EP EP12766838.2A patent/EP2768972B2/en active Active
- 2012-09-21 HR HRP20211523TT patent/HRP20211523T1/hr unknown
- 2012-09-21 SI SI201231960T patent/SI3623481T1/sl unknown
- 2012-09-21 DK DK17180583T patent/DK3290528T3/da active
- 2012-09-21 ES ES17180583T patent/ES2752653T3/es active Active
- 2012-09-21 HU HUE19189927A patent/HUE056246T2/hu unknown
- 2012-09-21 WO PCT/US2012/056556 patent/WO2013044018A1/en not_active Ceased
- 2012-09-21 DK DK12766838.2T patent/DK2768972T3/da active
- 2012-09-21 PT PT171805831T patent/PT3290528T/pt unknown
- 2012-09-21 SM SM20210624T patent/SMT202100624T1/it unknown
- 2012-09-21 DK DK19189927.7T patent/DK3623481T3/da active
- 2012-09-21 EP EP21189843.2A patent/EP3981886A1/en not_active Withdrawn
- 2012-09-21 PT PT191899277T patent/PT3623481T/pt unknown
- 2012-09-21 PL PL19189927T patent/PL3623481T3/pl unknown
- 2012-09-21 LT LTEP19189927.7T patent/LT3623481T/lt unknown
- 2012-09-21 ES ES12766838T patent/ES2639938T5/es active Active
- 2012-09-21 ES ES19189927T patent/ES2895184T3/es active Active
-
2016
- 2016-07-12 US US15/207,892 patent/US10287629B2/en active Active
-
2019
- 2019-05-07 US US16/405,679 patent/US10900077B2/en active Active
-
2021
- 2021-01-20 US US17/153,309 patent/US11827932B2/en active Active
- 2021-11-25 CY CY20211101027T patent/CY1125261T1/el unknown
-
2023
- 2023-10-18 US US18/489,788 patent/US20240141428A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240141428A1 (en) | Methods and compositions for nucleic acid sequencing | |
| CN107835809A (zh) | 具有长斯托克斯位移的多次甲基化合物及其作为荧光标记物的用途 | |
| CN101525660A (zh) | 实时序列测定 | |
| KR102749871B1 (ko) | 폴리뉴클레오티드의 시퀀싱 방법 | |
| CN114250283B (zh) | 基于环境敏感染料的单色荧光mrt基因测序试剂及方法 | |
| US20220195516A1 (en) | Methods, systems and compositions for nucleic acid sequencing | |
| CN115323045A (zh) | 一种基因测序试剂及基因测序方法 | |
| HK40073095A (en) | Compositions for nucleic acid sequencing | |
| HK40014484A (en) | Compositions for nucleic acid sequencing | |
| HK40014484B (en) | Compositions for nucleic acid sequencing | |
| HK1247254B (en) | Methods and compositions for nucleic acid sequencing | |
| HK1201079B (en) | Methods and compositions for nucleic acid sequencing | |
| US20230304086A1 (en) | Labeled avidin and methods for sequencing | |
| HK40049621B (zh) | 对多核苷酸进行测序的方法 |